Your browser doesn't support javascript.
loading
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy.
Kang, Tae Heung; Mao, Chih-Ping; Kim, Young Seob; Kim, Tae Woo; Yang, Andrew; Lam, Brandon; Tseng, Ssu-Hsueh; Farmer, Emily; Park, Yeong-Min; Hung, Chien-Fu.
Afiliação
  • Kang TH; Department of Immunology, College of Medicine, Konkuk University, 268, Chungju, South Korea.
  • Mao CP; MD-PhD Program, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Kim YS; Graduate Program in Immunology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Kim TW; Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Yang A; Department of Immunology, College of Medicine, Konkuk University, 268, Chungju, South Korea.
  • Lam B; Division of Infection and Immunology, Graduate School of Medicine, Korea University, Seoul, South Korea.
  • Tseng SH; Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Farmer E; MD-PhD Program, Baylor College of Medicine, Houston, TX, USA.
  • Park YM; Graduate Program in Immunology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Hung CF; Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
J Immunother Cancer ; 7(1): 260, 2019 10 16.
Article em En | MEDLINE | ID: mdl-31619293
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor Toll-Like 9 / Microambiente Tumoral / DNA Tumoral Circulante / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor Toll-Like 9 / Microambiente Tumoral / DNA Tumoral Circulante / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article